CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-28 | ICAHN CARL C 10% owner | Option exercise | +694,023 | 6,598,886 | ||
| 2014-11-28 | ICAHN CARL C 10% owner | Other disposition | −694,023 | 5,904,863 | ||
| 2014-11-28 | ICAHN CARL C 10% owner | Option exercise · Total Return Swap | −1 | 0 | ||
| 2014-11-28 | ICAHN CARL C 10% owner | Other acquisition · Total Return Swap | +1 | 1 | ||
| 2013-09-19 | LEBUHN ROBERT Director | Sale | −21,119 | $1.69 | $36K | 42,189 |
| 2013-09-17 | LEBUHN ROBERT Director | Sale | −34,807 | $1.74 | $60K | 63,308 |
| 2013-01-23 | Rackear Andrew D. VP and General Counsel | Grant or award | +4,686 | 78,019 | ||
| 2013-01-23 | Buchbinder Aby VP, Clinical Development | Grant or award | +3,748 | 79,246 | ||
| 2013-01-23 | Conover Charles SVP, R&D Program Management | Grant or award | +2,343 | 74,793 | ||
| 2013-01-02 | Young Richard A Director | Grant or award · Stock Option (Right to Buy) | +20,129 | 20,129 | ||
| 2013-01-02 | Deuel Thomas Director | Grant or award · Stock Option (Right to Buy) | +20,129 | 20,129 | ||
| 2013-01-02 | SALISBURY ROBERT C Director | Grant or award · Stock Option (Right to Buy) | +20,129 | 20,129 | ||
| 2013-01-02 | Mulligan Richard Director | Grant or award · Stock Option (Right to Buy) | +35,226 | 35,226 | ||
| 2013-01-02 | LEBUHN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +20,129 | 20,129 | ||
| 2013-01-02 | DENNER ALEXANDER J Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2012-11-28 | ICAHN CARL C 10% owner | Option exercise | +694,023 | 6,598,886 | ||
| 2012-11-28 | ICAHN CARL C 10% owner | Other disposition | −694,023 | 5,904,863 | ||
| 2012-11-28 | ICAHN CARL C 10% owner | Option exercise · Total Return Swap | −1 | 0 | ||
| 2012-11-28 | ICAHN CARL C 10% owner | Other acquisition · Total Return Swap | +1 | 1 | ||
| 2012-11-07 | HEBARD GEORGE Interim PEO and Interim COO | Grant or award | +24,500 | 43,237 |
Page 5 of 12 · 223 trades